Membrane Transportation

Membrane Transportation

Which ABC transporter plays a role in cholesterol and phospholipid transport in hepatocytes?

Row labeled Q30 appears truncated but query addresses which ABC transporter handles cholesterol and phospholipid transport in hepatocytes. In canalicular membrane ABCB4 MDR3 is established phosphatidylcholine floppase essential for biliary phospholipid secretion, pairing with bile salt export via ABCB11 and cholesterol export via ABCG5/G8. Its ATP-driven flipping of phosphatidylcholine to outer leaflet allows bile acids to extract lipid into mixed micelles that solubilize cholesterol and buffer bile acid detergent toxicity. At sinusoidal membrane, ABCA1 effluxes cholesterol and phospholipid to apolipoprotein A1 forming nascent HDL, contributing to reverse cholesterol transport. ABCB1 MDR1 exports amphipathic drugs xenobiotics rather than bulk biliary lipids, while SGLT1 and SGLT2 are sodium-glucose cotransporters secondary active members of SLC5 family irrelevant to lipid secretion. Clinically ABCB4 defects produce low-phospholipid bile, cholestasis, cholelithiasis and progressive liver injury, highlighting distinct partitioning of lipid transport functions among hepatic ABC proteins for bile formation and systemic lipoprotein metabolism. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Borst et al., Annu Rev Biochem 2000, ABC transporters in lipid transport; Alberts, Chapter 11.

View Details

Membrane Transportation

Which ABC transporter plays a role in cholesterol and phospholipid transport in hepatocytes?

Cholesterol and phospholipid homeostasis in hepatocytes involves coordinated action of several ABC transporters at canalicular membrane. ABCB4 MDR3 flips phosphatidylcholine from inner to outer leaflet making it available for bile salt extraction forming mixed micelles that protect biliary epithelium and solubilize cholesterol exported by ABCG5/G8 heterodimer. ABCB1 MDR1 primarily exports hydrophobic xenobiotics and drugs, not bulk phospholipid for bile formation, though it can translocate short-chain lipids in vitro. ABCA1, not listed among options but relevant, mediates phospholipid and cholesterol efflux to apolipoprotein A1 for nascent HDL biogenesis at basolateral side. SGLT family members SLC5A1 and SLC5A2 are sodium-glucose symporters secondary active, unrelated to lipid transport. Mutations in ABCB4 cause progressive familial intrahepatic cholestasis type 3 with low biliary phospholipid, cholangitis and cholelithiasis, while ABCG5/G8 defects cause sitosterolemia, demonstrating specific partitioning of cholesterol and phosphatidylcholine pathways among distinct ABC transporters in liver physiology and disease. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Oude Elferink & Paulusma 2007, Hepatic lipid transporters; Nicolaou et al., J Hepatol 2012.

View Details

Membrane Transportation

What is the primary function of Na+/K+ ATPase in maintaining secondary active transport?

Primary role of Na+/K+ ATPase in context of secondary active transport is generation and maintenance of electrochemical sodium gradient that powers numerous symporters and antiporters. By pumping three Na+ outward and two K+ inward per ATP hydrolyzed, it creates chemical gradient low intracellular Na+ and electrical gradient interior negative near minus 70 mV. Combined sodium motive force represents stored free energy. Solute carrier families SLC5 SGLT, SLC6 neurotransmitter transporters, SLC38 amino acid transporters, SLC9 NHE and SLC8 NCX exploit this force allowing Na+ to move downhill while accumulating glucose, amino acids, phosphate or extruding H+ and Ca2+ uphill. Without pump activity Na+ accumulates intracellularly, gradient collapses, concentrative nutrient absorption in gut and kidney fails, pH regulation falters, calcium overload occurs via reverse Na+/Ca2+ exchanger. Ouabain inhibition illustrates dependence. Thus pump does not directly carry glucose but indirectly energizes secondary systems, explaining coupling between primary and secondary active transport in animal cells for nutrient uptake and homeostasis.

Ref: Alberts et al., 7th ed., Chapter 11, Na+/K+ pump and secondary transport coupling.

View Details

Membrane Transportation

Which ion transporter is defective in cystic fibrosis?

Cystic fibrosis is monogenic disease caused by dysfunction of chloride and bicarbonate channel CFTR, ABCC7, not by Na+/K+ ATPase primary gradient generator nor by V-type proton pump acidifying organelles nor by ABCB1 drug efflux pump. CFTR localized apically in respiratory epithelium, pancreatic ductules, sweat duct, intestinal crypts and male reproductive tract mediates cAMP-activated Cl- secretion driving fluid movement and maintaining airway surface liquid hydration and mucus viscosity. Loss-of-function reduces chloride and bicarbonate secretion, leads to thickened secretions, obstructive lung disease with chronic Pseudomonas infection, pancreatic insufficiency, meconium ileus, and elevated sweat chloride above 60 mmol/L diagnostic hallmark. More than 2000 mutations including F508del, G551D, R117H impair trafficking, gating or conductance. Therapeutic correctors and potentiators target CFTR directly. Na+/K+ ATPase generates electrochemical gradient consumed by secondary transporters, V-ATPase acidifies lysosomes, ABCB1 effluxes xenobiotics, none cause hallmark multisystem chloride transport defect seen in cystic fibrosis. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Riordan et al., Annu Rev Biochem 2008, CFTR and cystic fibrosis; Davies et al., Science 2023.

View Details

Membrane Transportation

Which of the following describes V-class ATPases?

V-class ATPases, vacuolar type H+-ATPases, are multi-protein rotary pumps distinct from glucose carriers SGLT or drug exporters ABCB1. They hydrolyze ATP in cytosolic V1 sector comprising A3B3 catalytic hexamer and use released energy to rotate central stalk and translocate protons through membrane-embedded Vo sector containing c-ring proteolipids and subunit a. Cellular localization includes lysosomes, endosomes, trans-Golgi network, synaptic vesicles, secretory granules, osteoclast ruffled border and kidney intercalated cell apical membrane. By acidifying compartments to pH 4.5-5.5 they create environment for acid hydrolase activation, protein processing, neurotransmitter loading via proton-coupled secondary transporters, and iron release from transferrin. In osteoclasts and kidney they pump H+ outward contributing to bone resorption and urine acidification. They do not transport glucose, which uses SGLT and GLUT families, nor export lipophilic drugs, which uses ABC transporters, and they are not restricted to bacteria but broadly expressed in eukaryotes for organellar pH regulation vital for autophagy and infection defense.

Ref: Forgac, Nat Rev Mol Cell Biol 2007, V-ATPase function; Nelson & Harvey, Annu Rev Cell Biol 1999.

View Details

Membrane Transportation

The ABC transporter CFTR is unique because:

CFTR ABCC7 stands as atypical member of ABC superfamily because evolution transformed an active exporter scaffold into ATP-gated ion channel. Typical ABC exporters use ATP binding and hydrolysis to drive large TMD movements translocating substrate uphill. In CFTR, transmembrane domains create chloride-selective pore allowing passive flow down electrochemical gradient when open, while nucleotide-binding domains still bind ATP and regulate gating rather than transport solute stoichiometrically. Two ATP sites: NBD1 non-canonical hydrolyzes slowly, NBD2 drives channel closure upon hydrolysis. Additionally R domain phosphorylation by protein kinase A is required to permit NBD dimerization and opening. Thus transport is not solute-coupled uphill pumping but gated diffusion of Cl- and HCO3-, regulating airway surface liquid volume. This unique adaptation explains why potentiators like ivacaftor increase open probability and correctors assist folding, strategies distinct from inhibitors targeting classical ABC efflux pumps that expel hydrophobic drugs. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Gadsby et al., Nature 2006, Unique CFTR channel mechanism; Hwang & Sheppard, 2009.

View Details

Membrane Transportation

Which of the following describes SGLT2?

Sodium glucose cotransporters SGLT1 SLC5A1 and SGLT2 SLC5A2 are secondary active members using sodium gradient but differ in location, affinity and role. SGLT1 expressed predominantly in apical brush border of small intestine enterocytes and early kidney proximal tubule S3 is high-affinity low-capacity with 2 Na+ to 1 glucose stoichiometry handling dietary glucose and galactose absorption and some glucose reabsorption. SGLT2 localized exclusively in S1 and S2 segments of proximal tubule is low-affinity high-capacity with 1 Na+ to 1 glucose stoichiometry accounting for roughly 90 percent renal glucose reabsorption of filtered load near 180 g per day. Dysfunction produces renal glycosuria. SGLT2 inhibitors gliflozins empagliflozin and dapagliflozin block renal reabsorption promoting glycosuria, used for type 2 diabetes with cardiovascular benefits. Describing SGLT2 as intestinal transporter conflates families; SGLT1 dominates gut while SGLT2 dominates kidney. Neither functions as proton pump or cystic fibrosis related channel. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Wright et al., Physiol Rev 2011, SGLT1 vs SGLT2 distribution and physiology.

View Details

Membrane Transportation

Which transporter regulates bile phospholipid transport in hepatocytes?

Phosphatidylcholine supply to bile is governed by canalicular ABC transporter ABCB4, also known as multidrug resistance protein 2 or 3 in rodents and humans. This ATP-driven floppase actively translocates endogenous phosphatidylcholine from inner cytoplasmic leaflet to outer exoplasmic leaflet of hepatocyte canalicular membrane. Bile salts secreted via ABCB11 then extract phospholipid into bile forming mixed micelles that solubilize cholesterol and shield ductal epithelium from detergent toxicity of bile acids. ABCB1 MDR1 contributes to hydrophobic xenobiotic efflux but does not move bulk phosphatidylcholine for bile; Na+/K+ ATPase generates sodium gradient but does not directly handle biliary lipids; GLUT family facilitators transport monosaccharides, not phospholipids. Mutations in ABCB4 cause progressive familial intrahepatic cholestasis type 3 and low-phospholipid-associated cholelithiasis, linking transporter dysfunction to gallstone disease, fibrosis and cholestasis, illustrating specific regulation of biliary lipid composition by dedicated floppase rather than generic drug exporter. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Oude Elferink & Paulusma, Pflugers Arch 2007, ABCB4 phosphatidylcholine transport.

View Details

Membrane Transportation

In secondary active transport, lactose permease in E. coli utilizes:

Secondary active lactose permease LacY does not itself hydrolyze ATP nor perform direct phosphorylation of sugar substrate like phosphotransferase systems that import glucose as glucose-6-phosphate. Instead energy source is electrochemical proton gradient across E. coli inner membrane established by respiratory chain proton pumping. Lactose entry is strictly coupled to downhill H+ flow: one proton symported per lactose disaccharide. Experimental evidence shows that abolishing proton motive force with uncouplers carbonyl cyanide m-chlorophenyl hydrazone, nigericin, or by inhibiting respiration eliminates lactose accumulation even when ATP remains available, whereas glycolysis inhibitors that deplete ATP but preserve respiration spare transport. Sodium gradient is irrelevant for LacY though analogous bacterial MelB uses both ions. Therefore in textbook classification, lactose permease illustrates proton gradient-driven secondary active co-transport distinct from primary ABC importers requiring ATP binding proteins and sodium-dependent mammalian SGLT transporters driven by Na+ gradient. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Kaback et al., J Gen Physiol 2008, Proton coupling LacY; Poolman et al., Mol Microbiol 2004.

View Details

Membrane Transportation

Which ABC transporter is associated with multidrug resistance in cancer?

Cancer multidrug efflux is dominated not by CFTR or P-type ATPases but by ABC transporters that expel amphipathic chemotherapeutics from cytoplasm. ABCB1 P-glycoprotein MDR1 is best studied, overexpressed in colonic, renal, adrenocortical carcinomas and after chemotherapy induction in leukemia, lymphoma and breast cancer. Its polyspecific hydrophobic binding chamber accommodates doxorubicin, daunorubicin, vinblastine, vincristine, paclitaxel and etoposide causing cross-resistance. ABCC1 MRP1 exports glutathione conjugates of drugs, ABCG2 BCRP expels mitoxantrone and topotecan. Expression correlates with poor response, reduced disease-free interval, and altered pharmacokinetics influencing oral bioavailability and blood-brain barrier penetration. Mechanistically transporter uses ATP hydrolysis at two NBDs to switch from inward-high affinity to outward-low affinity releasing drug. Inhibitors verapamil, cyclosporine, tariquidar attempted clinically to reverse resistance, but toxicity and redundant export pathways limit success, prompting development of nanoparticle formulations to bypass efflux and selective modulators. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Gottesman et al., Annu Rev Med 2002, MDR in cancer; Szakacs et al., Nat Rev Drug Discov 2006.

View Details

Membrane Transportation

The ABC transporter in plants responsible for detoxification of xenobiotics is found in:

Plants lack animal Na+/K+ gradient but generate proton motive force via plasma membrane P-type H+-ATPase and vacuolar V-type H+-ATPase and pyrophosphatase, driving uptake and compartmentalization of metabolites. Detoxification of xenobiotics, herbicides, and endogenous secondary metabolites employs ATP-binding cassette transporters localized predominantly in vacuolar membrane tonoplast and plasma membrane. Vacuolar ABCC members often called MRP-like transport glutathione S-conjugates, phytochelatin heavy metal complexes, and glucuronide conjugates into vacuole for sequestration, reducing cytosolic toxicity. Plasma membrane ABCG members extrude antimicrobial terpenoids and cuticular lipids. In Arabidopsis, AtABCC1 and AtABCC2 are classic vacuolar transporters conferring tolerance to arsenic and cadmium phytochelatin complexes. Tonoplast localization enables long-term storage away from sensitive metabolic processes, paralleling hepatic canalicular ABC exporters. Exclusive peroxisomal or endoplasmic reticulum residence is not typical for xenobiotic detoxification ABC pumps; tonoplast and plasma membrane are major detox sites contributing to environmental adaptation. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Martinoia et al., Planta 2002, Vacuolar transporters; Kang et al., PNAS 2011, ABC in detox.

View Details

Membrane Transportation

Which of the following is not a characteristic of secondary active transport?

Secondary active transport refers to movement of solute against its concentration gradient energized indirectly by ion electrochemical gradient established by primary active pumps, not by direct ATP binding and hydrolysis at transport protein itself. Hallmarks include dependence on Na+/K+ ATPase or H+-ATPase to maintain Na+ or H+ motive force, inhibition by collapse of gradient with ionophores or ouabain, and involvement of symport or antiport mechanisms where downhill flow of driving ion drags substrate uphill. Protein operates by alternating access rocker-switch mechanism without Walker A ATP-binding motifs. Therefore direct ATP consumption at transporter characterizes primary active class exemplified by P-type ATPases such as Na+/K+ ATPase, Ca2+ ATPase SERCA, and ABC exporters where ATP hydrolysis at NBDs directly powers movement. Assigning direct ATP utilization to secondary systems is inaccurate; they utilize gradient, so feature of primary pumps cannot be defining for secondary transport. Symport and antiport, gradient utilization remain defining features. Such detailed mechanistic insight is frequently examined in competitive tests including NEET, CUET, CSIR-NET and GATE where transporter classification, energetics and disease linkage are integrated into problem-solving questions.

Ref: Alberts et al., 7th ed., Chapter 11, Distinction primary vs secondary active transport.

View Details